overview of urothelial carcinoma treatment landscape – the promise of immunotherapy
Published 7 years ago • 422 plays • Length 4:00Download video MP4
Download video MP3
Similar videos
-
2:05
the evolving treatment landscape of advanced and metastatic urothelial carcinoma
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
4:49
advanced upper urinary tract urothelial carcinoma: treatment landscape and remaining challenges
-
2:02
the evolving treatment landscape for urothelial cancer
-
2:35
urothelial carcinoma treatment: the future
-
0:44
role of immunotherapy in bladder cancer
-
0:58
replacing the current standard of care for urothelial carcinoma
-
56:27
ccf webinar: a clinical trial for a potential new ther2apy for biliary tract cancers
-
2:03
the evolution of bladder cancer treatment and the immuno-oncology era
-
2:31
key immunotherapy combinations for urothelial cancer
-
1:23
recent advances in the use of targeted therapies for metastatic urothelial carcinoma
-
3:50
recommendations for the treatment of muscle and non-muscle invasive urothelial carcinoma
-
1:17
recent advances in the treatment of upper tract urothelial carcinoma
-
7:32
the promise of immunotherapy in bladder cancer
-
1:03
dr. pal on the sequencing of immunotherapy for urothelial carcinoma
-
4:31
current obstacles in the treatment of urothelial carcinoma
-
5:48
immunotherapy in metastatic urothelial carcinoma
-
2:02
sacituzumab govitecan in the treatment of metastatic urothelial carcinoma
-
1:08:04
understanding the evolving treatment landscape in bladder cancer